Natera

Yahoo Finance • 5 days ago

5 Must-Read Analyst Questions From Natera’s Q1 Earnings Call

Natera’s first quarter was marked by robust top-line growth and higher-than-expected sales volumes, but the market responded negatively due to a wider-than-anticipated GAAP loss. Management attributed the revenue momentum primarily to stro... Full story

Yahoo Finance • 20 days ago

Natera Inc. (NTRA): Billionaire Tom Steyer’s Stock Pick with Huge Upside Potential

We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Natera, Inc. (NASDAQ:NTRA) ranks 3rd on this list. Natera, Inc. (NASDAQ:NTRA) has been a staple in the 13F portfolio of Farallon Capital since the seco... Full story

Yahoo Finance • 21 days ago

William Blair Initiates Natera (NTRA) With Outperform

Natera, Inc. (NASDAQ:NTRA) is one of the Stocks that Billionaire Druckenmiller and Jim Cramer like.William Blair Initiates Natera (NTRA) With Outperform William Blair initiated coverage of Natera, Inc. (NASDAQ:NTRA) with an Outperform rat... Full story

Yahoo Finance • 24 days ago

Should You Be Bullish on Natera (NTRA)?

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. Baron Health Care Fund (the Fund) declined 6.97% (Institutional Sha... Full story

Yahoo Finance • last month

3 Reasons We’re Fans of Natera (NTRA)

Natera has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6%. The stock now trades at $208.20, marking a 10.5% gain. This was partly thanks to its solid quarterly results, and the performance may ha... Full story

Yahoo Finance • last month

3 Reasons NTRA Has Explosive Upside Potential

Even during a down period for the markets, Natera has gone against the grain, climbing to $211.23. Its shares have yielded a 22.1% return over the last six months, beating the S&P 500 by 23.8%. This was partly due to its solid quarterly re... Full story

Yahoo Finance • last month

Natera awarded 30% ongoing royalty in MRD patent litigation

Natera (NTRA [https://seekingalpha.com/symbol/NTRA]) on Thursday said the United States District Court for the District of Delaware has ordered an ongoing 30% royalty on certain post-injunction sales tied to its long-running patent dispute... Full story

Yahoo Finance • 2 months ago

Stanley Druckenmiller Loaded Up on This Stock That’s Down 77%

Quick Read Sea (SE) surged 244.3% in Druckenmiller’s portfolio to 944k shares worth $120M, now constituting 2.85% of his holdings, as the company trades at just 10x free cash flow despite 17.2% three-year revenue growth and 10x profit exp... Full story

Yahoo Finance • 2 months ago

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 2 months ago

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. The retreat in oil prices provided temporary relief to a market that was volatil... Full story

Yahoo Finance • 2 months ago

3 Growth Stocks to Add to Your Roster

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. Luckily for you, our job at StockStory is to h... Full story

Yahoo Finance • 2 months ago

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

Key Points Eversept Partners added 264,468 shares of Vera Therapeutics in the fourth quarter; the estimated transaction value was $9.39 million based on quarterly average pricing. Meanwhile, the quarter-end position value increased in val... Full story

Yahoo Finance • 2 months ago

Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More

Quick Read Citi is positioning selectively across life sciences by favoring recovery names with clear catalysts while avoiding companies navigating accounting uncertainty, with Agilent’s pending Biocare deal removal expected to drive mult... Full story

Yahoo Finance • 2 months ago

3 Healthcare Stocks to Target This Week

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 5.7% over the past six month... Full story

Yahoo Finance • 3 months ago

Signatera Oncology Test Drives Natera’s (NTRA) Growth

Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter can be downloaded here. The fourth quarter of 2025 saw mixed res... Full story

Yahoo Finance • 3 months ago

Natera: Q4 Earnings Snapshot

AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Natera Inc. (NTRA) on Thursday reported fourth-quarter net income of $47.3 million. On a per-share basis, the Austin, Texas-based company said it had net income of 35 cents. The results topped Wa... Full story

Yahoo Finance • 3 months ago

Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks

Key Points One investment is a fast-growing genetic testing company that's now generating cash flow and has a scalable business model. The leading semiconductor foundry's sales are booming on AI-led demand, but expanding cash-flow margin... Full story

Yahoo Finance • 3 months ago

Philippe Laffont's Strategic Exit from CoreWeave Inc: A -2.26% Portfolio Impact

This article first appeared on GuruFocus. Insights into Philippe Laffont (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Warning! GuruFocus has detected 9 Warning Signs with BHP. Is TSM fairly valued? Test your thesis with our... Full story

Yahoo Finance • 3 months ago

Stanley Druckenmiller's Strategic Moves: A Closer Look at State Street Financial Select Sector ...

This article first appeared on GuruFocus. Insights from the Fourth Quarter 2025 13F Filing Stanley Druckenmiller (Trades, Portfolio) recently submitted his 13F filing for the fourth quarter of 2025, revealing strategic investment decisio... Full story

Yahoo Finance • 5 months ago

Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study

Natera, Inc. (NASDAQ:NTRA) is one of the High Growth Large Cap Stocks to Buy Right Now.On December 18, the company announced publication of the findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology. CAL... Full story